1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2019

Immunomodulator use does not prevent first loss of response to anti-tumour necrosis factor alpha therapy in inflammatory bowel disease: long-term outcomes in a real-world cohort

Varma, P., Rajadurai, A., Holt, D. Q., Devonshire, D. A., Desmond, C., Swan, M. P., Nathan, D., Shelton, E., Prideaux, L., Sorrell, C., Rusli, F., Crantock, L. RF., Dev, A., Ratnam, D., Pianko, S. & Moore, G., 1 Jun 2019, In : Internal Medicine Journal. 49, 6, p. 753-760 8 p.

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Retreatment with elbasvir, grazoprevir, sofosbuvir ± ribavirin is effective for GT3 and GT1/4/6 HCV infection after relapse

Papaluca, T., Sinclair, M., Gow, P., Pianko, S., Sievert, W., Arachchi, N., Cameron, K., Bowden, S., O’Keefe, J., Doyle, J., Stoove, M., Hellard, M., Iser, D. & Thompson, A., 1 Dec 2019, In : Liver International. 39, 12, p. 2285-2290 6 p.

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)
2018

Australian recommendations for the management of hepatitis C virus infection: a consensus statement (September 2018)

Hepatitis C Virus Infection Consensus Statement Working Group, 2018, Melbourne VIC Australia: Gastroenterology Society of Australia. 71 p.

Research output: Book/ReportCommissioned ReportOther

Open Access
File
2017

Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 – final results of the REV1TAL study

Lubel, J., Strasser, S., Stuart, K. A., Dore, G., Thompson, A., Pianko, S., Bollipo, S., Mitchell, J. L., Fragomeli, V., Jones, T., Chivers, S., Gow, P., Iser, D., Levy, M., Tse, E., Gazzola, A., Cheng, W., Nazareth, S., Galhenage, S., Wade, A. & 8 others, Weltman, M., Wigg, A., MacQuillan, G., Sasadeusz, J., George, J., Zekry, A., Roberts, S. K. & the Australian Liver Association Clinical Research Network (ALA CRN), 2017, In : Antiviral Therapy. 22, 8, p. 699-710 12 p.

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)

Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials

Gane, E. J., Pianko, S., Roberts, S. K., Thompson, A. J., Zeuzem, S., Zuckerman, E., Ben-Ari, Z., Foster, G. R., Agarwal, K., Laursen, A. L., Gerstoft, J., Gao, W., Huang, H. C., Fitzgerald, B., Fernsler, D., Li, J. J., Grandhi, A., Liu, H., Su, F. H., Wan, S. & 11 others, Zeng, Z., Chen, H. L., Dutko, F. J., Nguyen, B. Y. T., Wahl, J., Robertson, M. N., Barr, E., Yeh, W. W., Plank, R. M., Butterton, J. R. & Esteban, R., 1 Nov 2017, In : The Lancet Gastroenterology & Hepatology. 2, 11, p. 805-813 9 p.

Research output: Contribution to journalArticleResearchpeer-review

17 Citations (Scopus)
2015

Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection

Foster, G. R., Pianko, S., Brown, A., Forton, D. M., Nahass, R. G., George, J., Barnes, E., Brainard, D., Massetto, B., Lin, M., Han, B., McHutchison, J. G., Subramanian, G. M., Cooper, C. & Agarwal, K., 2015, In : Gastroenterology. 149, 6, p. 1462 - 1470 9 p.

Research output: Contribution to journalArticleResearchpeer-review

167 Citations (Scopus)

Sofosbuvir plus velpatasvir combination therapy for treatment- Experienced patients with genotype 1 or 3 Hepatitis c virus infection

Pianko, S., Flamm, S. L., Shiffman, M. L., Kumar, S., Strasser, S. I., Dore, G. J., McNally, J., Brainard, D., Han, L., Doehle, B., Mogalian, E., McHutchison, J. G., Rabinovitz, M., Towner, W. J., Gane, E. J., Stedman, C. A. M., Reddy, K. R. & Roberts, S. K., 2015, In : Annals of Internal Medicine. 163, 11, p. 809 - 817 9 p.

Research output: Contribution to journalArticleResearchpeer-review

60 Citations (Scopus)
2013

IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-alpha

Holmes, J., Nguyen, T., Ratnam, D., Heerasing, N. M., Tehan, J. V., Bonanzinga, S., Dev, A. T., Bell, S., Pianko, S., Chen, R., Visvanathan, K., Hammond, R. A., Iser, D., Rusli, F., Sievert, W., Bowden, S. & Thompson, A. J., 2013, In : Journal of Gastroenterology and Hepatology. 28, 5, p. 861 - 866 6 p.

Research output: Contribution to journalArticleResearchpeer-review

35 Citations (Scopus)

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

Jacobson, I. M., Gordon, S. C., Kowdley, K. V., Yoshida, E., Rodriguez-Torres, M., Sulkowski, M. S., Shiffman, M. L., Lawitz, E., Everson, G. T., Bennett, M., Schiff, E., Al-Assi, M. T., Subramanian, G. M., An, D., Lin, M., McNally, J., Brainard, D., Symonds, W. T., McHutchison, J. G., Patel, K. & 3 others, Feld, J., Pianko, S. & Nelson, D. R., 2013, In : The New England Journal of Medicine. 368, 20, p. 1867 - 1877 11 p.

Research output: Contribution to journalArticleResearchpeer-review

863 Citations (Scopus)
2012

Efficacy and tolerability of pegylated interferon-alpha-2a in chronic hepatitis B: a multicenter clinical experience

Ratnam, D., Dev, A. T., Nguyen, T., Sundararajan, V., Harley, H., Cheng, W., Lee, A., Rusli, F., Chen, R., Bell, S., Pianko, S. & Sievert, W., 2012, In : Journal of Gastroenterology and Hepatology. 27, 9, p. 1447 - 1453 7 p.

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

Pianko, S., Zeuzem, S., Chuang, W. L., Foster, G., Sarin, S. K., Flisiak, R., Lee, C-M., Andreone, P., Piratvisuth, T., Shah, S., Sood, A., George, J., Gould, M., Komolmit, P., Thongswat, S., Tanwandee, T., Rasenack, J., Li, Y., Pang, M., Yin, Y. & 2 others, Feutren, G. & Jacobson, I. M., 2012, In : Journal of Viral Hepatitis. 19, 9, p. 623 - 634 12 p.

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)
2008

Albinterferon alfa-2b dosed every two or four weeks in interferon-naive patients with genotype 1 chronic hepatitis C

Zeuzem, S., Yoshida, E., Benhamou, Y., Pianko, S., Bain, V. G., Shouval, D., Flisiak, R., Rehak, V., Grigorescu, M., Katia, K., Cronin, P. W., Pulkstenis, E., Subramanian, G. M. & McHutchison, J. G., 2008, In : Hepatology. 48, 2, p. 407 - 417 11 p.

Research output: Contribution to journalArticleResearchpeer-review

80 Citations (Scopus)
2006

Sustained virological response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical setting

Desmond, C. P., Roberts, S., Dudley, F., Mitchell, J., Day, C., Nguyen, S. & Pianko, S., 2006, In : Journal of Viral Hepatitis. 13, 5, p. 311 - 315 5 p.

Research output: Contribution to journalArticleResearchpeer-review

51 Citations (Scopus)
2005

Survival in hepatocellular carcinoma: Impact of screening and etiology of liver disease

Kemp, W. W., Pianko, S., Nguyen, S., Bailey, M. J. & Roberts, S., 2005, In : Journal of Gastroenterology and Hepatology. 20, p. 873 - 881 9 p.

Research output: Contribution to journalArticleResearchpeer-review

57 Citations (Scopus)

The clinical utility of using Catrimox-14-treated whole blood in detecting hepatitis C virus RNA

Patel, K., Albrecht, J., Owens, E., Dev, A., Heaton, S., Pianko, S., Pockros, P., Conrad, A., Blatt, L. & McHutchison, J., 2005, In : Antiviral Therapy. 10, 4, p. 535 - 541 7 p.

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)
2004

The direct cost of managing patients with chronic hepatitis B infection in Australia

Butler, J., Pianko, S., Rosemary, K. J., Nguyen, S., Gow, P., Roberts, S., Strasser, S. I. & Sievert, W., 2004, In : Journal of Clinical Gastroenterology. 38, 10, p. 187 - 192 6 p.

Research output: Contribution to journalArticleResearchpeer-review

13 Citations (Scopus)
2003

Induction interferon and ribavirin for re-treatment of chronic hepatitis C patients unresponsive to interferon alone

Sievert, W., Batey, R., Mollison, L., Pianko, S., McDonald, J., Marinos, G., Reed, W., Warner, S., Bowden, D. S., De Solom, R. & Bhathal, P. S., 2003, In : Alimentary Pharmacology & Therapeutics. 17, 9, p. 1197 - 1204 8 p.

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)
2002

Hepatic iron overload does not prevent a sustained virological response to interferon-α therapy: A long term follow-up study in hepatitis C-infected patients with β thalassemia major

Sievert, W., Pianko, S., Warner, S., Bowden, S., Simpson, I., Bowden, D. & Locarnini, S., 29 Apr 2002, In : The American Journal of Gastroenterology. 97, 4, p. 982-987 6 p.

Research output: Contribution to journalArticleResearchpeer-review

41 Citations (Scopus)
2001
82 Citations (Scopus)
2000

Alcohol consumption induces hepatocyte apoptosis in patients with chronic hepatitis C infection

Pianko, S., Patella, S. & Sievert, W., Jul 2000, In : Journal of Gastroenterology and Hepatology. 15, 7, p. 798-805 8 p.

Research output: Contribution to journalArticleResearchpeer-review

26 Citations (Scopus)

Apoptosis and viral hepatitis

Pianko, S., McCaughan, G., Sievert, W. & McHutchison, J. G., 1 Dec 2000, In : Viral Hepatitis Reviews. 6, 1-4, p. 93-109 17 p.

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)
1997

Apoptosis is increased in hepatitis C infection but not in autoimmune hepatitis

Pianko, S., Patella, S. & Sievert, W., 1997, p. A1359 - A1359. 1 p.

Research output: Contribution to conferenceAbstract

Exposure of Kupffer cells to iron results in altered function and a significant reduction in ROS production

Pianko, S., Patella, S. & Sievert, W., 1997, p. 342A - 342A. 1 p.

Research output: Contribution to conferenceAbstract

Hepatocyte Apoptosis is increased in chronic HCV infection and Alcohol Use

Pianko, S. & Sievert, W., 1997, p. A1359 - A1359. 1 p.

Research output: Contribution to conferenceAbstract

1994

The 1-month outcome of patients with a low probability technegas ventilation/perfusion lung scan

Bellomo, R., Low, R., Pianko, S., Korman, A., Clarke, K., White, S. & Wong, C., 1 Jan 1994, In : Nuclear Medicine Communications. 15, 7, p. 505-510 6 p.

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)